Evoke Pharma

Youtube Subscribe

Open: 1.03 Close: 1.0 Change: -0.03

How to know if Evoke Pharma Stock is a risky investment without reading the whole internet.

The game is changing. There is a new strategy to evaluate Evoke Pharma fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Evoke Pharma are: Evoke, last, negative, share, trade, Pharma, NASDAQEVOK, …

Concept Map

Semantic Network

Stock Summary

Evoke Pharma, Inc. offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists.

Today's Summary

Evoke Pharma ( NASDAQ:EVOK – Get Free Report ) last issued its quarterly earnings data on Thursday, November 9th. The company had a negative return on equity of 517.99% and a negative net margin of 176.93%. Evoke shares last traded at $1.03, with a volume of 2,718 shares traded.

Today's News

Evoke Pharma ( NASDAQ:EVOK – Get Free Report ) last issued its quarterly earnings data on Thursday, November 9th. The company had a negative return on equity of 517.99% and a negative net margin of 176.93%. Evoke shares last traded at $1.03, with a volume of 2,718 shares traded.

Stock Profile

"Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California."

Keywords

Are looking for the most relevant information about Evoke Pharma? Investor spend a lot of time searching for information to make investment decisions in Evoke Pharma. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Evoke Pharma are: Evoke, last, negative, share, trade, Pharma, NASDAQEVOK, and the most common words in the summary are: llc, inc, pharmaceutical, ltd, co, pharma, company, . One of the sentences in the summary was: Evoke Pharma ( NASDAQ:EVOK – Get Free Report ) last issued its quarterly earnings data on Thursday, November 9th. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #llc #inc #pharmaceutical #ltd #co #pharma #company.

Read more →

Youtube Subscribe

---